extracorporeal photochemotherapy

extracorporeal photochemotherapy

a procedure for treating pemphigus vulgaris by treating the patient's blood outside the body. Certain drugs are first administered to the patient. Some of the patient's blood is then removed temporarily for exposure to ultraviolet light outside the body. The blood, after treatment, is returned to the patient. See also photochemotherapy.

extracorporeal photochemotherapy

The exposure of blood that is temporarily removed from the body to ultraviolet A radiation. This is used to treat several diseases, including pemphigus vulgaris and cutaneous T cell lymphoma.

CAUTION!

Patients exposed to photosensitizing agents, such as psoralens in conjunction with ultraviolet light, have an increased risk of melanoma and squamous cell carcinoma. They should be examined regularly so that any developing skin cancers will be detected early.
References in periodicals archive ?
Treating refractory chronic graft-versus-host disease with extracorporeal photochemotherapy.
Treatment of extensive chronic graft-versus-host disease with extracorporeal photochemotherapy.
Other treatment modalities that have been tried include photochemotherapy, methotrexate, topical calcipotriol, keratolytics, cyclosporine, azathioprine, fumaric acid esters, extracorporeal photochemotherapy and tumor necrosis factor alpha antagonists i.
Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versus-host disease.
Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy.
Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: a pilot study.
Contract notice: Supply and service of a treatment system ( fotoinattivazione ) for extracorporeal photochemotherapy .
Investigators found that Targretin capsule therapy reliably induced rapid responses in these erythrodemic patients who had been refractory to interferon, extracorporeal photochemotherapy, electron beam radiotherapy, photochemotherapy with ultraviolet-A, topical chemotherapy, systemic chemotherapy, and combinations of these therapies.
Object is the expectation of the delivery service of a system for extracorporeal photochemotherapy and everything needed for the irradiation of mononuceate cells with UV-A rays in the presence of 8-MOPP (inclusive of irradiator and disposable kits) and reinfusion of the cell concentrate patient undergoing radiation and the supply of consumables and support tecnica.
Building contracts divided into two parts deliveries are 1) three pieces of therapeutic separators intended for routine diagnosis of extracorporeal photochemotherapy and preparation of mononuclear cells to anti-tumor vaccines2) 1 piece separator for donor interventions - the separation of platelets deleucotized in line at a centrifugal separation procedure.
Building contracts divided into two parts deliveries are:1) three pieces of therapeutic separators intended for routine diagnosis for extracorporeal photochemotherapy and preparation of mononuclear cells in a cancer vaccine;2) 1 piece separator for donor interventions - the separation of platelets deleucotized in line at a centrifugal separation procedure.

Full browser ?